Abstract
Introduction
Over the past decade, vaccines have resurfaced as an attractive commercial
proposition for Pharma. The developed world has been the initial focus of
vaccine makers due to the better healthcare infrastructure and higher price
levels. However, facing increasingly saturated markets in the West, companies
are looking to expand into new geographies, such as Asia' s emerging markets.
Scope of this research
- Strategic analysis of key domestic vaccine companies as well as the
position of major international players
- Thorough assessment of the market environment for vaccines in India,
China, Taiwan and Korea
- Review of existing vaccine recommendations, coverage rates and promising
future indications
- In-depth discussion of strengths, weaknesses, opportunities and threats
for each market from a vaccine maker' s perspective
Research and analysis highlights
Immunizations in India are currently restricted to a limited public
vaccination schedule, with the insufficient healthcare infrastructure in rural
areas contributing to low coverage rates. Commercial opportunities lie in
providing premium vaccines to the emerging private sector and in partnering
with domestic players.
China is a very challenging market for international vaccine companies. The
country remains difficult to penetrate due to the high language and cultural
barriers, opaque regulatory environment and strong government influence. Local
expertise and connections are crucial, making partnerships with domestic
players a key strategy for market access.
With only one domestic vaccine player, Taiwan relies on imports. Looking to
decrease the country' s reliance on imports and to establish it as a hub for
biotechnology, the Taiwanese government is encouraging international vaccine
makers to build manufacturing and R&D facilities in the country, offering tax
rebates and advance purchase agreements.
Key reasons to purchase this research
- Review portfolios and deals for key domestic vaccine companies as well as
the position of major international vaccine makers
- Gain insight into the market environment for vaccines through a review of
demographic, economic and regulatory trends
- Understand challenges, unmet needs and future opportunities by learning
about the views of key opinion leaders from each country
| 
View Cart
